Navigation Links
Veracyte Announces Appointment of Shelly D. Guyer as Chief Financial Officer
Date:4/12/2013

SOUTH SAN FRANCISCO, Calif., April 12, 2013 /PRNewswire/ -- Veracyte, Inc., a molecular diagnostics company pioneering the emerging field of molecular cytology, today announced the appointment of Shelly D. Guyer as chief financial officer.

"We are delighted to welcome Shelly Guyer to the Veracyte team," said Bonnie Anderson , Veracyte's cofounder and chief executive officer. "Her extensive background in the life science and finance industries will be critical as we experience strong growth of our first product, the Afirma® Thyroid FNA Analysis, and as we expand our molecular cytology platform to other clinical areas to similarly help reduce unnecessary surgeries and lower healthcare costs." Ms. Anderson noted that data published in the New England Journal of Medicine suggest that Veracyte's genomic test for improved thyroid cancer diagnosis can potentially help tens of thousands of patients each year in the United States avoid thyroid surgery.

Ms. Guyer previously was chief financial officer and executive vice president of finance and administration at iRhythm Technologies, a private, venture-backed medical device and services company. Prior to that, she served on the management team and as vice president of business development and investor relations at Nuvelo, a public biotechnology company. Ms. Guyer began her business career at J.P. Morgan Securities and its predecessor companies, where for over 17 years she held various positions, including principal and vice president of health care banking for the West Coast, leading financings for a variety of large and small cap life science companies.

"I am pleased to join the talented management team at Veracyte," said Ms. Guyer. "The company's mission of helping patients avoid surgery is compelling.
'/>"/>

SOURCE Veracyte, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Veracyte Announces Medicare Coverage for Its Afirma® Gene Expression Classifier for Improved Thyroid Nodule Diagnosis
2. Veracyte Appoints Mark Spring as Chief Financial Officer
3. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentations of Zerenex™ (Ferric Citrate) at the Upcoming American Society of Nephrology Kidney Week 2011 Annual Meeting
4. VaxyGen Assay Services, LLC Announces Launch of Custom Bioassay Services and Operations
5. Sequenom Announces Participation at the Lazard Capital Markets 8th Annual Healthcare Conference
6. ACORN Research, LLC Announces Partnership with AdeptBio, LLC
7. GeoVax Labs, Inc. Announces Nine Month 2011 Financial Results
8. WuXi PharmaTech Announces Third-Quarter 2011 Results
9. Chimerix Announces Late-Breaking Poster Presentation at Kidney Week 2011 Annual Meeting
10. Spherix Announces Third Quarter Financial Results
11. Modern Mobility Aids, Inc. Announces November 30, 2011 Closing of Lumigene Acquisition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... July 23, 2014 StemGenex® , ... in the US aimed at improving the lives of ... clinical study for Parkinson’s disease. StemGenex believes that ... cell therapy are paramount when providing care to patients ... makes stem cell therapy accessible to the millions of ...
(Date:7/23/2014)... 2014 - Valentis ... Trendlines Agtech , announced it has signed an ... leading agricultural thermoplastics applications companies. ... combines nanocrystalline cellulose (NCC), a biodegradable, transparent material ... to produce highly improved polymeric films. Used as ...
(Date:7/23/2014)... Iowa (PRWEB) July 23, 2014 DuPont ... the business as vice president of Agricultural Biotechnology (ABT), ... Biotechnology where he served most recently as president, chief ... biotechnology and business leadership in the seed and crop ... said Paul E. Schickler , president of DuPont ...
(Date:7/23/2014)... /PRNewswire/ - BioAmber Inc. (NYSE: BIOA ... announced that the underwriters of its common stock ... an additional 420,000 shares of common stock at ... less underwriting discounts and commissions, in connection with ... shares of common stock, bringing the expected net ...
Breaking Biology Technology:StemGenex® Gives Hope to Parkinson’s Patients through New Stem Cell Clinical Study 2StemGenex® Gives Hope to Parkinson’s Patients through New Stem Cell Clinical Study 3Valentis Nanotech Signs MOU to Integrate Technology in Thermoplastics Production 2DuPont Pioneer Names Neal Gutterson to Lead Agricultural Biotechnology 2DuPont Pioneer Names Neal Gutterson to Lead Agricultural Biotechnology 3BioAmber announces exercise in full of underwriters' option in connection with previously priced follow-on offering 2BioAmber announces exercise in full of underwriters' option in connection with previously priced follow-on offering 3
... Calif., Nov. 7 InterMune, Inc.,(Nasdaq: ITMN ) ... and President of InterMune, will present at Deutsche,Bank,s 2008 ... p.m. EST., To access a live audio webcast ... on to the investor relations page of InterMune,s,corporate website ...
... NeoGenomics, Inc.,(OTC Bulletin Board: NGNM) announced today ... present at the Rodman & Renshaw,10th Annual Healthcare ... New York Palace Hotel in New York City. ... public life sciences and biotech companies.,Gasparini and other ...
... Inc. (OTC,Bulletin Board: AIMM) today reported a net loss of ... three months ended September 30, 2008,compared with a net loss ... the three months ended September 30, 2007. For the nine ... $0.01 per share,basic and diluted, compared with net loss of ...
Cached Biology Technology:NeoGenomics to Present at the Rodman & Renshaw Healthcare Conference on November 10 2AutoImmune Inc. Reports 2008 Third Quarter Financial Results 2AutoImmune Inc. Reports 2008 Third Quarter Financial Results 3
(Date:7/23/2014)... 2014 BCC Research ... GLOBAL MARKETS AND TECHNOLOGIES FOR SENSORS , the global ... grow to nearly $154.4 billion by 2020, with a ... image, flow, and level sensors segment is moving at ... http://photos.prnewswire.com/prnh/20140723/694805 ) , Sensors have become indispensable ...
(Date:7/23/2014)... , July 23, 2014   MedNet Solutions ... in clinical study management systems, is pleased to ... proven life sciences industry executive with over 25 ... Officer (COO).  Clareece will be responsible for MedNet,s ... operational efficiency and quality product/service delivery.  ...
(Date:7/23/2014)... DNA has the nasty habit of getting tangled and ... function and learn how to disentangle them (e.g. useful ... International School for Advanced Studies (SISSA) in Trieste and ... they simulate these knots and their dynamics. In their ... Matter , Micheletti together with Marco Di Stefano, first ...
Breaking Biology News(10 mins):Global Market for Sensors to Reach Nearly $154.4 Billion in 2020; Image Sensors Moving at 11.7% 2Global Market for Sensors to Reach Nearly $154.4 Billion in 2020; Image Sensors Moving at 11.7% 3MedNet Appoints Clareece West As Chief Operating Officer 2
... Scott & White Healthcare in Temple, Texas, found that a new ... is unique in that it works both by stopping the cancer ... the immune system to destroy breast cancer cells and keeps them ... work in both ways, while all other treatments work in one ...
... , , ... Cotecna,Inspection SA, Philippines received accreditation from the Committee for,Accreditation ... break bulk,surveyor for cargo entering the Philippines. Cotecna is ... by the Philippine government under,their Administrative Order (AO) 243-A ...
... to drape those huge fake spider webs over doorways and ... long-standing mystery about real spider webs: It is the secret ... a new generation of biobased adhesives and glues "green" ... uses. A report on the study was published in ACS, ...
Cached Biology News:Scott & White Healthcare researcher finds success with new anti-cancer drug 2Cotecna Philippines Accredited as Bulk and Break Bulk Surveyor 2
... an 18 amino acid synthetic peptide whose sequences are derived from ... to carboxy terminus): S(21) - S - M - P - ... - A - I - D - K - K - ... This peptide may be used for neutralization and control experiments with ...
... System, Basic Package Superior Protein Detection ... The ProXPRESS 2D Proteomic Imaging System is ... both proteomic and general life science research ... the use of all dyes in the ...
... peptide microarrays designed for quantitative assays ... and built on the flexible and ... of customer specified sequences can be ... provide assistance with custom sequence design. ...
... extended-length microarrays are custom designed to meet ... are available: 8,455 features per array (2 ... features per array (1 array/slide). ... length - This extended length delivers ...
Biology Products: